Blood cancer can be fatal if not detected early; innovative biosensors with machine learning optimization enable timely diagnosis by identifying cancer-specific biomarkers in blood, improving survival ...
MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences Corp. (Nasdaq: EXAS), a leader in cancer diagnostics, today announced the launch of the Cancerguard™ test, a new multi-cancer early detection (MCED) ...
A multicancer early detection (MCED) test was developed and validated in the case-control Circulating Cell-free Genome Atlas (CCGA) study (ClinicalTrials.gov identifier: NCT02889978). Previous ...
A new light-based sensor can spot incredibly tiny amounts of cancer biomarkers in blood, raising the possibility of earlier and simpler cancer detection. The technology merges DNA nanotechnology, ...
A new type of blood test could help detect multiple cancers early. A team of researchers in California studied a new multi-cancer early detection (MCED) test called Galleri, which can reportedly ...
The company is running a new platform set up to minimize false negative results as well as avoiding false positives. (Getty Images) Harbinger Health has grabbed $100 million in its latest funding ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results